Bifidobacterium breve M-16V and Reduced Mortality Risk

• Bifidobacterium breve M‐16V as a Probiotic for Preterm Infants: A Strain‐Specific Systematic Review

  • 2017-12-19
  • Journal of Parenteral and Enteral Nutrition 42(4)
  • • G. Athalye-Jape
    • Shripada C Rao
    • K. Simmer
    • S. Patole

  • PubMed: 28796951
  • DOI: 10.1177/0148607117722749

  4 Insights on

  • Reduced Mortality Risk

  • Low evidence

  Meta-analysis of non-RCTs showed significant benefits on ... (2) mortality-2 studies (n = 2319), odds ratio = 0.61 (95% CI, 0.44-0.84), P = .002

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes